Lancet Oncology

The Lancet Oncology was launched in September, 2000, as a lively and informative monthly journal covering international issues relevant to clinical cancer specialists worldwide. The journal is now the world-leading clinical oncology periodical publishing high-quality, peer-reviewed research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academic centres). Content covers topics that advance clinical practice, challenge the status quo, advocate change in health policy, and tackle issues related to global oncology. Much of the journal’s articles are published Online First for enhanced timeliness prior to print publication. Uniquely, all original research is peer-reviewed via a fast-track service, and successful papers are published within 8 weeks of submission. The journal also regularly features podcasts, video, infographics, and curated web content.

Publisher
Elsevier
Website
http://www.thelancet.com/journals/lanonc/issue/current
Impact factor
33.9 (2016)

Some content from Wikipedia, licensed under CC BY-SA

Medical research

Immunotherapy drug for advanced lung cancer shows promise

Lung cancer spreads to the brain in about one-quarter of patients with an advanced form of the disease. To date, radiation has been the only treatment option, but it comes with toxic side effects. Researchers at Yale Cancer ...

Oncology & Cancer

Breakthrough in childhood brain cancer

Scientists led by Newcastle University have been able to identify the group of children needing more intensive, aggressive chemotherapy treatment for the most common form of brain cancer.

Oncology & Cancer

Pediatric cancer drug shows 93 percent response rate

A first-of-its-kind drug targeting a fused gene found in many types of cancer was effective in 93 percent of pediatric patients tested, researchers at UT Southwestern's Simmons Cancer Center announced.

Genetics

Researchers unveil new gene subgroup in prostate cancer

Prostate cancer researchers have drawn a molecular portrait that provides the first complete picture of localized, multi-focal disease within the prostate and also unveils a new gene subgroup driving it.

Oncology & Cancer

Popular weed killer deemed probable carcinogen by UN

One of the world's most popular weed-killers—and the most widely used kind in the U.S.—has been labeled a probable carcinogen by the International Agency for Research on Cancer.

Oncology & Cancer

Overweight linked to 500,000 cancer cases per year

Overweight and obesity is now causing nearly half a million new cancer cases in adults every year, roughly 3.6 percent of the world's total, a study said Wednesday.

page 1 from 26